Ethical, Legal, and Social Implications (ELSI) of Microdose Clinical Trials
Advanced drug delivery reviews 2011 Jun 19; 63(7): 503-10
A "microdose clinical trial" (microdosing) is one kind of early phase exploratory clinical trial, administering the compound at doses estimated to have no pharmacological or toxicological effects, aimed at screening candidates for further clinical development. This article's objective is to clarify the ethical, legal, and social implications (ELSI) of such an exploratory minimum-risk human trial. The definition and non-clinical study requirements for microdosing have been harmonized among the European Union (EU), United States (US), and Japan. Being conducted according to these regulations, microdosing seems to be ethically well justified in terms of respect for persons, beneficence, justice, human dignity, and animal welfare. Three big projects have been demonstrating the predictability of therapeutic dose pharmacokinetics from microdosing. The article offers suggestions as how microdosing can become a more useful and socially accepted strategy.
Showing items related by title, author, creator and subject.
The ELSI Hypothesis [book review of GENE MAPPING: USING LAW AND ETHICS AS GUIDES edited by George J. Annas and Sherman Elias; THE CODE OF CODES: SCIENTIFIC AND SOCIAL ISSUES IN THE HUMAN GENOME PROJECT edited by Daniel J. Kevles and Leroy Hood; LE GENOME HUMAIN: UNE RESPONSABILITE SCIENTIFIC ET SOCIALE edited by Marcel J. Melancon and Raymond D. Lambert; BIBLIOGRAPHY: ETHICAL, LEGAL AND SOCIAL IMPLICATIONS OF THE HUMAN GENOME PROJECT edited by Michael S. Yesley] Lindee, M. Susan (1994-06)